COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,796 Articles (22,527 medRxiv, 8,269 bioRxiv)

Most recent first Previous |  Page 628: Articles 6271-6280  | Next

NO2 pollution decrease in big cities of Latin America during COVID-19 pandemic
Poullain, M., Guerrieri, J. M., Miller, M., Utges, M. E., Santini, M. S., Manteca Acosta, M., Fernandez, A. D., Marsico, F. L.
10.1101/2022.08.08.22277819 — Posted: 2022-08-09
Effects of behavioral restrictions on COVID-19 spread
Sasaki, K., Ikeda, Y., Nakano, T.
10.1101/2022.08.08.22278490 — Posted: 2022-08-09
A study to assess the impact of cobas Liat point-of-care PCR assays (SARS-CoV-2 and Influenza A/B) on patient clinical management in the emergency department of the University of California at Davis Medical Center
May, L., Robbins, E., Canchola, J. A., Chugh, K., Tran, N. K.
10.1101/2022.08.08.22278536 — Posted: 2022-08-09
Infectiousness of SARS-CoV-2 breakthrough infections and reinfections during the Omicron wave
Tan, S. T., Kwan, A. T., Rodriguez-Barraquer, I., Singer, B. J., Park, H. J., Lewnard, J. A., Sears, D., Lo, N. C.
10.1101/2022.08.08.22278547 — Posted: 2022-08-09
COVID-19 pandemic responses may impact the spread of antibiotic-resistant bacteria: a modelling study
Kovacevic, A., Smith, D. R. M., Rahbe, E., Novelli, S., Henriot, P., Temime, L., Opatowski, L.
10.1101/2022.08.08.503267 — Posted: 2022-08-09
Acetylsalicylic acid and Salicylic acid inhibit SARS-CoV-2 replication in precision-cut lung slices
Geiger, N., König, E.-M., Oberwinkler, H., Roll, V., Diesendorf, V., Faehr, S., Obernolte, H., Sewald, K., Wronski, S., Steinke, M., Bodem, J.
10.1101/2022.08.09.503270 — Posted: 2022-08-09
Vitamin B12 attenuates leukocyte inflammatory signature in COVID-19 via methyl-dependent changes in epigenetic marks
Cassiano, L. M. G., Silva, V. C., Oliveira, M. S., Prado, B. V. O., Cardoso, C. G., Salim, A. C. M., Franco, G. R., D'Almeida, V., Francisco, S. C., Coimbra, R. S.
10.1101/2022.08.08.503231 — Posted: 2022-08-09
A replicon RNA vaccine induces durable protective immunity from SARS-CoV-2 in nonhuman primates after neutralizing antibodies have waned
O'Connor, M. A., Hawman, D. W., Meade-White, K., Leventhal, S., Song, W., Randall, S., Archer, J., Lewis, T. B., Brown, B., Iwayama, N., Ahrens, C., Garrison, W., Wangari, S., Guerriero, K. A., Hanley, P., Lovaglio, J., Saturday, G., Edlefsen, P. T., Khandhar, A., Feldmann, H., Fuller, D. H., Erasmus, J. H.
10.1101/2022.08.08.503239 — Posted: 2022-08-09
Activation of the urotensin-II receptor by anti-COVID-19 drug remdesivir induces cardiomyocyte dysfunction
Wei, F.-Y., Inoue, A., Ogawa, A., Ohira, S., Ikuta, T., Kato, Y., Yanagida, S., Ishii, Y., Kanda, Y., Nishida, M.
10.1101/2022.08.08.503256 — Posted: 2022-08-09
Broad immunity to SARS-CoV-2 variants of concern mediated by a SARS-CoV-2 receptor-binding domain protein vaccine
Deliyannis, G., Gherardin, N. A., Wong, C. Y., Grimley, S. L., Cooney, J. P., Redmond, S., Ellenberg, P., Davidson, K., Mordant, F. L., Smith, T., Gillard, M., Lopez, E., McAuley, J., Tan, C. W., Wang, J., Zeng, W., Littlejohn, M., Zhou, R., Chan, J. F.-W., Chen, Z.-w., Hartwig, A. E., Bowen, R., Mackenzie, J. M., Vincan, E., Torresi, J., Kedzierska, K., Pouton, C. W., Gordon, T., Wang, L.-f., Kent, S. J., Wheatley, A. K., Lewin, S. R., Subbarao, K., Chung, A., Pellegrini, M., Munro, T., Nolan, T., Rockman, S., Jackson, D. C., Purcell, D. F. J., Godfrey, D. I.
10.1101/2022.08.05.22278425 — Posted: 2022-08-09

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).